申请人:BEIJING JIALIN PHARMACEUTICAL INC.
公开号:US11332461B2
公开(公告)日:2022-05-17
Provided are a compound of formula (I) or a pharmaceutically acceptable salt, stereoisomer, ether, ester, prodrug and solvate thereof. The compound can be used for preventing and/or treating cancers.
本文提供了一种式(I)化合物或其药学上可接受的盐、立体异构体、醚、酯、原药和溶液。该化合物可用于预防和/或治疗癌症。